CVS Weight Management Program Yields 15% Average Weight Loss, 26% Cost Saving Among Participants

On Friday, CVS Health Inc CVS released data from the CVS Weight Management program, in which participants achieved more than 15% weight loss on average. This included existing anti-obesity medication users who succeeded in nearly doubling their pre-program weight loss while working with program clinicians on diet and lifestyle.

Results are derived from a population of 265,000 members from 2023-2024. 

The initial results demonstrate improved weight loss and high program satisfaction for CVS Caremark clients’ plan members trying a lifestyle-first approach, as well as additional clinical effectiveness and cost savings for members receiving clinical support while taking weight management medications like GLP-1s.

Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!

GLP-1 products from Novo Nordisk A/S NVO and Eli Lilli And Co LLY have gained substantial traction. The CVS Weight Management program provides one-on-one support from a dedicated registered dietitian in a virtual setting, including personalized nutrition planning.

The program can integrate into a member’s existing pharmacy benefit with plan sponsors’ direction.

CVS Caremark clients who adopted the CVS Weight Management program spent up to 26% less on GLP-1 medications for weight loss than clients who did not adopt the program.

The program also has a lasting impact, with 92% of participating plan members expressing satisfaction after six months.

As of February 1, 2025, the CVS Weight Management program is now available to over 3.5 million CVS Caremark plan members.

Despite FDA prescription drug labeling recommendations to take GLP-1’s in combination with diet and physical activity, 70% of members were using a weight management drug without any lifestyle or nutrition support before enrolling in the CVS Weight Management program.

• Before program enrollment, nearly 30% of members had lost less than 1% of their body weight on anti-obesity medication. These same members lost, on average, 11.7% of body weight after enrollment.
• The program accelerated weight loss and delivered an average of 20% weight loss for those with moderate success before enrollment.
• Members who chose to discontinue anti-obesity medication and retain lifestyle support maintained 94% of their weight loss after 6 months.

Read Next:

• Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.
• If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

Photo via Shutterstock